Compare Exelixis Inc. Common Stock (EXEL) vs Huntington Ingalls Industries Inc (HII) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Exelixis Inc. Common Stock vs Huntington Ingalls Industries Inc — how do they compare? Exelixis Inc. Common Stock trades at $59.77 (market cap $14.62B), while Huntington Ingalls Industries Inc trades at $264.76 (market cap $10.44B). The key difference: Exelixis Inc. Common Stock is the larger of the two by market cap, and Huntington Ingalls Industries Inc pays a 2.08% dividend while Exelixis Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Exelixis Inc. Common Stock for 1 Days and Huntington Ingalls Industries Inc for 28 Days on average.
| EXEL | HII | |
|---|---|---|
Market Cap | $14.62B | $10.44B |
Volume | 2,684,957 | 440,462 |
Sector | Health | Industrials |
52-Week High | $59.13 | $453.73 |
52-Week Low | $34.54 | $257.05 |
Typical Hold Time | 1 Days | 28 Days |
Enterprise Value | $13.95B | $13.37B |
Dividend Yield | — | 2.08% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
HII trades at $264.80, up 1.58% today, with a bearish technical signal from moving averages. The company shows solid fundamentals with a P/E of 15.78, net income margin of 5.01%, and a $57.3 billion backlog supporting revenue visibility. Recent contract wins, including a $5.1 billion aircraft carrier overhaul and 10 unmanned vessel orders, highlight operational momentum amid consistent earnings beats.
The outlook is supported by strong defense budgets and execution, but risks include project delays and macroeconomic pressures. Analysts are generally positive with a $363.67 consensus target, implying significant upside, though technical indicators suggest near-term caution.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Exelixis Inc. Common Stock
Exelixis develops and commercializes medicines for cancer. Its research focuses on targeted therapies for oncology.
Read more on EXEL →About Huntington Ingalls Industries Inc
Huntington Ingalls is the largest military shipbuilder in the U.S. and a provider of professional services to government and industry partners, specializing in nuclear-powered submarines and aircraft carriers.
Read more on HII →
